Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biogen Inc (BIIB)

Biogen Inc (BIIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 53,679,600
  • Shares Outstanding, K 174,064
  • Annual Sales, $ 14,378 M
  • Annual Income, $ 5,889 M
  • 60-Month Beta 1.21
  • Price/Sales 3.75
  • Price/Cash Flow 8.03
  • Price/Book 4.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 7.83
  • Number of Estimates 27
  • High Estimate 8.70
  • Low Estimate 6.91
  • Prior Year 6.98
  • Growth Rate Est. (year over year) +12.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
267.59 +15.25%
on 01/31/20
374.99 -17.76%
on 02/05/20
+26.44 (+9.38%)
since 01/28/20
3-Month
267.59 +15.25%
on 01/31/20
374.99 -17.76%
on 02/05/20
+5.04 (+1.66%)
since 11/27/19
52-Week
215.77 +42.92%
on 09/04/19
374.99 -17.76%
on 02/05/20
-19.62 (-5.98%)
since 02/28/19

Most Recent Stories

More News
After Yesterday's Decline of 1.39%, Biogen Inc Offers Investors Better Value

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $299.00 to a high of $309.37. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $315.46...

BIIB : 308.39 (-0.55%)
SmarTrend Watching for Potential Rebound in Shares of Biogen Inc After 1.39% Loss

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $299.00 to a high of $309.37. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $315.46...

BIIB : 308.39 (-0.55%)
Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimer's, Parkinson's, Neuromuscular, and Other Neurological Diseases

Biogen Inc. (Nasdaq: BIIB) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that they have executed a global licensing collaboration agreement to develop and commercialize...

BIIB : 308.39 (-0.55%)
SGMO : 8.53 (+28.08%)
Biogen Inc Falls 2.44% on Heavy Volume: Watch For Potential Rebound

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $331.17 to a high of $336.00. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $332.50...

BIIB : 308.39 (-0.55%)
Biogen Inc Set to Possibly Rebound After Yesterday's Selloff of 2.44%

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $331.17 to a high of $336.00. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $332.50...

BIIB : 308.39 (-0.55%)
Stocks Turn Sharp Plunge into Modest Selloff

Stocks Turn Sharp Plunge into Modest Selloff

BIIB : 308.39 (-0.55%)
ENTG : 53.32 (+3.92%)
ABC : 84.32 (-2.62%)
MLNX : 119.42 (+0.29%)
HUBB : 133.24 (+0.35%)
BC : 53.20 (-1.99%)
BMCH : 24.53 (-3.23%)
BLMN : 17.99 (-2.39%)
YETI : 30.25 (+2.75%)
RUBI : 11.35 (+6.37%)
HQY : 70.99 (-3.99%)
EVRI : 10.40 (-5.45%)
Zacks Market Edge Highlights: Tesla, Micron, Biogen, GameStop and Maxar Technologies

Zacks Market Edge Highlights: Tesla, Micron, Biogen, GameStop and Maxar Technologies

BIIB : 308.39 (-0.55%)
MU : 52.56 (+3.91%)
GME : 3.60 (+3.75%)
TSLA : 667.99 (-1.62%)
MAXR : 15.21 (+2.77%)
Stocks the Pros Loved Heading into 2020

As stocks hit new all-time highs to finish 2019, the professional money managers were busy positioning their portfolios for 2020. What were they buying, and selling, heading into the new year?

BIIB : 308.39 (-0.55%)
MU : 52.56 (+3.91%)
GME : 3.60 (+3.75%)
TSLA : 667.99 (-1.62%)
MAXR : 15.21 (+2.77%)
Bull of the Day: Guardant Health (GH)

Bull of the Day: Guardant Health (GH)

UNH : 254.96 (+0.41%)
NVTA : 20.38 (+0.74%)
GH : 86.96 (+12.70%)
EXAS : 80.95 (+0.16%)
BIIB : 308.39 (-0.55%)
AMGN : 199.73 (-1.85%)
Wanna Be a Value Investor? Follow Buffett & Play 2 ETF Areas

Warren Buffett took positions in Biogen and Kroger. Investors who want to follow Buffett's picking of these two value stocks can also play these ETFs as well.

BIIB : 308.39 (-0.55%)
AMZN : 1,883.75 (-0.03%)
WMT : 107.68 (-2.46%)
KR : 28.13 (-0.81%)
IBB : 113.88 (+0.40%)
BBH : 134.30 (+0.58%)
FTXD : 21.89 (-2.40%)
FXG : 43.50 (-1.85%)
IEIH : 26.27 (-1.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BIIB with:

Business Summary

Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia,...

See More

Key Turning Points

2nd Resistance Point 317.52
1st Resistance Point 312.95
Last Price 308.39
1st Support Level 301.41
2nd Support Level 294.44

See More

52-Week High 374.99
Fibonacci 61.8% 314.17
Last Price 308.39
Fibonacci 50% 295.38
Fibonacci 38.2% 276.60
52-Week Low 215.77

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar